Article info
Short report
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design
- Correspondence to Dr Francesco D Tiziano, Istituto di Genetica Medica, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1 00168 Roma, Italy; fdtiziano{at}rm.unicatt.it
Citation
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design
Publication history
- Received April 21, 2010
- Revised June 8, 2010
- Accepted June 9, 2010
- First published September 12, 2010.
Online issue publication
November 22, 2010
Article Versions
- Previous version (12 September 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.